Stockscreener 앱 받기
1.99
5.69%
-0.12
시간 외 거래:
1.97
-0.02
-1.01%
전일 마감가:
$2.11
열려 있는:
$1.95
하루 거래량:
204.25K
Relative Volume:
0.91
시가총액:
$81.83M
수익:
$1.88M
순이익/손실:
$-15.57M
주가수익비율:
-4.975
EPS:
-0.4
순현금흐름:
$-50.09M
1주 성능:
+0.51%
1개월 성능:
-4.78%
6개월 성능:
-28.67%
1년 성능:
+21.34%
1일 변동 폭
$1.9053
$2.09
1주일 범위
$1.9053
$2.44
52주 변동 폭
$0.98
$3.44
Beyondspring Inc Stock (BYSI) Company Profile
명칭
Beyondspring Inc
전화
646-528-4184
주소
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
BYSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
1.99 | 86.77M | 1.88M | -15.57M | -50.09M | -0.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-12-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-12-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-12-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-09-09 | 개시 | Robert W. Baird | Outperform |
| 2021-08-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-04-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-01-11 | 개시 | BofA Securities | Buy |
| 2020-12-29 | 개시 | Evercore ISI | Outperform |
| 2020-02-07 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Nomura | Buy |
| 2019-12-03 | 개시 | William Blair | Outperform |
| 2019-07-10 | 재확인 | H.C. Wainwright | Buy |
| 2019-04-30 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-10-25 | 재확인 | Maxim Group | Buy |
모두보기
Beyondspring Inc 주식(BYSI)의 최신 뉴스
Beyondspring Delays Second Closings of Share Sale - TipRanks
BeyondSpring Inc. Announces Preferred Share Purchase Agreement - TradingView — Track All Markets
BeyondSpring (NASDAQ: BYSI) now expects SEED share Second Closings in 1H 2026 - Stock Titan
BYSI: Recent Business Developments Shape Market Outlook - StocksToTrade
BeyondSpring Inc. Stock Shows Upward Spike As Earnings Report Uncovers Surprises - StocksToTrade
BeyondSpring Stock Faces Challenges Amid Recent Market Dynamics - timothysykes.com
BeyondSpring Inc. Faces Financial Pressure in the Pharmaceutical Market - timothysykes.com
BYSI Stock Shows Turbulence Amid Financial Uncertainty - StocksToTrade
BYSI Stock Volatility Amidst Strategic Developments and Market Shifts - StocksToTrade
BYSI’s Stock Roller Coaster: What Happens Next? - StocksToTrade
BeyondSpring Inc.’s Market Shift: Analyzing Financial Trends and Price Movements - timothysykes.com
BeyondSpring’s Stock Gains Steam Amid Market Developments - timothysykes.com
BeyondSpring (BYSI) Stock :Surges 5% as New Plinabulin Data Strengthens Case for Global NSCLC Registration Path - CoinCentral
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 - marketscreener.com
BYSI: BeyondSpring's Plinabulin Shows Promising Results in Phase 3 Trial - GuruFocus
BeyondSpring stock rises after positive Asian subset data from lung cancer trial - Investing.com
BeyondSpring reports positive Asian subset data for lung cancer drug By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BeyondSpring (NASDAQ: BYSI) Phase 3 Asian data shows HR 0.69, cuts neutropenia to 3.9% - Stock Titan
BeyondSpring’s Plinabulin combination shows survival benefit in NSCLC - TipRanks
BeyondSpring (BYSI) Reports Promising Results for Plinabulin in Lung Cancer Study - GuruFocus
BeyondSpring Announces Positive Phase 3 DUBLIN-3 Results for Plinabulin in NSCLC Patients Post Anti-PD-(L)1 Therapy and Plans for Global DUBLIN-4 Trial - Quiver Quantitative
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 - marketscreener.com
BeyondSpring (NASDAQ: BYSI) DUBLIN-3 finds 15.8-month OS, fewer brain mets in NSCLC - Stock Titan
Why 22nd Century Group Inc stock could benefit from AI revolutionTrade Ideas & Accurate Buy Signal Notifications - moha.gov.vn
BeyondSpring Inc. Reports Q3 2025 Earnings and Strategic Shift - MSN
What Wall Street predicts for BeyondSpring Inc. stock priceMarket Growth Report & Fast Momentum Entry Tips - Newser
Is BeyondSpring Inc. stock in correction or buying zone2025 Technical Overview & Safe Capital Growth Tips - Newser
BeyondSpring (NASDAQ:BYSI) Shares Down 3.6%Should You Sell? - MarketBeat
Nasdaq Moves: What Wall Street predicts for BeyondSpring Inc stock priceMarket Weekly Review & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
BYSI SEC FilingsBeyondspring Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Will BeyondSpring Inc. stock benefit from AI adoptionTrade Volume Summary & Daily Entry Point Alerts - BỘ NỘI VỤ
Dividend Watch: Why BeyondSpring Inc. stock could benefit from AI revolutionProduct Launch & AI Based Buy and Sell Signals - moha.gov.vn
BeyondSpring Reports Third‐Quarter 2025 Financial Results and Provides Corporate Update - 富途牛牛
BeyondSpring Completes $2 Million Securities Agreement - TipRanks
Why BeyondSpring Inc. stock remains on watchlistsJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
How BeyondSpring Inc. stock valuations compare to rivalsOil Prices & Accurate Technical Buy Alerts - newser.com
How currency fluctuations impact BeyondSpring Inc. stock2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Will BeyondSpring Inc. stock reach all time highs in 20252025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
Is BeyondSpring Inc. stock a top pick in earnings season2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Using Bollinger Bands to evaluate BeyondSpring Inc.July 2025 Trade Ideas & Smart Money Movement Alerts - newser.com
Is BeyondSpring Inc. forming a bottoming base2025 Trade Ideas & Fast Gain Stock Tips - newser.com
What earnings revisions data tells us about BeyondSpring Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
[424B5] BeyondSpring Inc. Prospectus Supplement (Debt Securities) - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Beyondspring Inc (BYSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Beyondspring Inc 주식 (BYSI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Decheng Capital China Life Sci | 10% Owner |
Oct 17 '25 |
Sale |
1.76 |
45,513 |
80,103 |
1,518,893 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 13 '25 |
Sale |
1.70 |
107,361 |
182,514 |
1,696,659 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 14 '25 |
Sale |
1.65 |
28,495 |
47,017 |
1,668,164 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 15 '25 |
Sale |
1.65 |
17,960 |
29,634 |
1,650,204 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 08 '25 |
Sale |
1.77 |
7,507 |
13,287 |
1,810,389 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 09 '25 |
Sale |
1.81 |
3,979 |
7,202 |
1,806,410 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 10 '25 |
Sale |
1.77 |
2,390 |
4,230 |
1,804,020 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 06 '25 |
Sale |
1.78 |
17,500 |
31,150 |
1,819,996 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 07 '25 |
Sale |
1.79 |
2,100 |
3,759 |
1,817,896 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 03 '25 |
Sale |
1.76 |
600 |
1,056 |
1,837,496 |
0.36%
1.05%
자본화:
|
볼륨(24시간):